Cargando…
RET融合阳性晚期非小细胞肺癌治疗进展
Rearranged during transfection (RET) fusions are found in 0.7% to 2% of non-small cell lung cancer (NSCLC). Fusions between RET gene and other domains represent the distinct biological and clinicopathological subtypes of NSCLC. Recent years have witnessed the remarkable advancement of RET fusion-pos...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695242/ https://www.ncbi.nlm.nih.gov/pubmed/34743497 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.43 |